RxDoctor Payments Data

Steven Maximus, MD

Vascular Surgery · Houston, TXNPI 1730478082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $85,093 of the $140,120 with a category attached, or 60.7%. 25 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 59.0% of the total. 2025 is the largest year on record at $60,234, more than ten times the $1,701 reported in 2019. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$140,120in general payments, 2019–2025

Across 505 payments — averaging $277.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$83K
  • Silk Road Medical, Inc.$36K
  • Shockwave Medical, Inc$9K
  • Cook Medical LLC$4K
  • Medtronic$3K
  • Boston Scientific$2K
  • plus $5K from 19 others

What the payments were for

  • Consulting fees$85,09361%
  • Speaking & faculty fees$6,6005%
  • Grants$1430%
  • Travel & lodging$16,04811%
  • Food & beverage$32,23623%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$140,120 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$159,374
Medicare patients
747
Services billed
1,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate53$500
Cilostazol11$369
Atorvastatin Calcium18$277

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →